BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.41.90//
CALSCALE:GREGORIAN
UID:61613266-3361-4161-b136-356638616235
BEGIN:VEVENT
UID:53154ea410ae3432d7dc0a847e616bb2060f886b@swoogo.com
DTSTAMP:20260610T184501Z
DESCRIPTION:Dr. Toresson brings extensive clinical experience with FMT and 
 has published two major studies on its use in dogs with non-responsive or 
 partially responsive chronic enteropathies. In this case-based seminar\, s
 he will explore the rationale behind FMT\, review the latest research find
 ings\, and discuss how this therapy influences clinical and metabolic para
 meters in dogs with acute and chronic enteropathies. Current indications f
 or FMT will be examined\, and Dr Toresson will interpret real-world cases\
 , connecting them to emerging evidence and best practices.
DTSTART:20260114T190000Z
DTEND:20260114T203000Z
LAST-MODIFIED:20260610T184501Z
LOCATION:https://idexx.swoogo.com/011426ToressonSpecialistWebinar/v/e
SEQUENCE:0
STATUS:CONFIRMED
SUMMARY:1.14.26 Specialist Webinar Toresson Fecal Microbiota Transplantatio
 n: When and Why—A Case-Based Clinical Approach
TRANSP:OPAQUE
X-ALT-DESC;FMTTYPE=text/html:<p><span style='font-size:16px\;'><span style=
 'line-height:107%\;'><span style='font-family:Calibri\, sans-serif\;'>Dr. 
 Toresson brings extensive clinical experience with FMT and has published t
 wo major studies on its use in dogs with non-responsive or partially respo
 nsive chronic enteropathies. In this case-based seminar\, she will explore
  the rationale behind FMT\, review the latest research findings\, and disc
 uss how this therapy influences clinical and metabolic parameters in dogs 
 with acute and chronic enteropathies. Current indications for FMT will be 
 examined\, and Dr Toresson will interpret real-world cases\, connecting th
 em to emerging evidence and best practices.</span></span></span></p>
BEGIN:VALARM
UID:61623433-3963-4636-b035-666339316365
ACTION:DISPLAY
DESCRIPTION:Dr. Toresson brings extensive clinical experience with FMT and 
 has published two major studies on its use in dogs with non-responsive or 
 partially responsive chronic enteropathies. In this case-based seminar\, s
 he will explore the rationale behind FMT\, review the latest research find
 ings\, and discuss how this therapy influences clinical and metabolic para
 meters in dogs with acute and chronic enteropathies. Current indications f
 or FMT will be examined\, and Dr Toresson will interpret real-world cases\
 , connecting them to emerging evidence and best practices.
TRIGGER:-PT15M
END:VALARM
END:VEVENT
END:VCALENDAR